These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Increased Production of Lysozyme Associated with Bacterial Proliferation in Barrett's Esophagitis, Chronic Gastritis, Gluten-induced Atrophic Duodenitis (Celiac Disease), Lymphocytic Colitis, Collagenous Colitis, Ulcerative Colitis and Crohn's Colitis. Rubio CA Anticancer Res; 2015 Dec; 35(12):6365-72. PubMed ID: 26637845 [TBL] [Abstract][Full Text] [Related]
43. Controversies in the detection and management of nonsteroidal antiinflammatory drug-induced side effects of the upper gastrointestinal tract. Barrier CH; Hirschowitz BI Arthritis Rheum; 1989 Jul; 32(7):926-32. PubMed ID: 2787642 [No Abstract] [Full Text] [Related]
44. [Effects of nonsteroidal anti-inflammatory agents on the gastrointestinal tract]. Bures J; Rejchrt S; Kopácová M; Siroký M Cas Lek Cesk; 2002 Oct; 141(21):673-9. PubMed ID: 12564374 [TBL] [Abstract][Full Text] [Related]
45. Assessment and prevention of gastrointestinal toxicity of non-steroidal anti-inflammatory drugs. Lane ME; Kim MJ J Pharm Pharmacol; 2006 Oct; 58(10):1295-304. PubMed ID: 17034651 [TBL] [Abstract][Full Text] [Related]
46. Forthcoming non-steroidal anti-inflammatory drugs: are they really devoid of side effects? Bjarnason I Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S27-36. PubMed ID: 10379467 [TBL] [Abstract][Full Text] [Related]
48. Potential complications of nonsteroidal anti-inflammatory drug therapy. Corrigan GD; Pantig-Felix L; Kanat IO J Am Podiatr Med Assoc; 1989 Dec; 79(12):605-14. PubMed ID: 2696786 [TBL] [Abstract][Full Text] [Related]
49. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs. McCarthy DM Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039 [TBL] [Abstract][Full Text] [Related]
50. Histology of microscopic colitis-review with a practical approach for pathologists. Langner C; Aust D; Ensari A; Villanacci V; Becheanu G; Miehlke S; Geboes K; Münch A; Histopathology; 2015 Apr; 66(5):613-26. PubMed ID: 25381724 [TBL] [Abstract][Full Text] [Related]
51. The NSAIDs and the gastrointestinal mucosa. An update symposium. Oslo, 14 October 1988. Proceedings. Scand J Gastroenterol Suppl; 1989; 163():1-73. PubMed ID: 2814362 [No Abstract] [Full Text] [Related]
52. Management of non steroidal anti-inflammatory drug induced gastro-intestinal damage. McCormack PM Ir Med J; 1994; 87(2):27-8. PubMed ID: 8194941 [No Abstract] [Full Text] [Related]
53. Non-steroidal anti-inflammatory drugs use and risk of upper gastrointestinal adverse events in cirrhotic patients. Lee YC; Chang CH; Lin JW; Chen HC; Lin MS; Lai MS Liver Int; 2012 May; 32(5):859-66. PubMed ID: 22226322 [TBL] [Abstract][Full Text] [Related]
54. [Adverse effects of non-steroidal anti-inflammatory drugs]. Guzecka E; Czarnecki A Pol Tyg Lek; 1988 Jul; 43(29):931-6. PubMed ID: 2976932 [No Abstract] [Full Text] [Related]
56. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications]. ; Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333 [TBL] [Abstract][Full Text] [Related]
57. COX-2 selectivity alone does not define the cardiovascular risks associated with non-steroidal anti-inflammatory drugs. Warner TD; Mitchell JA Lancet; 2008 Jan; 371(9608):270-3. PubMed ID: 18207021 [No Abstract] [Full Text] [Related]
58. [Side effects of antirheumatic therapy on the gastrointestinal tract]. Voigt J; Kaesberger W; Grün M Z Rheumatol; 1987; 46 Suppl 1():76-82. PubMed ID: 3326365 [No Abstract] [Full Text] [Related]
59. Nonsteroidal anti-inflammatory drug-induced gastrointestinal damage. Current insights into patient management. Proceedings of a symposium. June 13, 1987, Washington, D.C. Am J Med; 1988 Feb; 84(2A):1-52. PubMed ID: 3348237 [No Abstract] [Full Text] [Related]